Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Mural Oncology Plc ( (MURA) ) has shared an announcement.
Mural Oncology plc has appointed Sachiyo Minegishi as a new independent director and Chair of the Audit Committee, with her term set to expire at the 2025 annual general meeting. Ms. Minegishi will receive a mix of cash compensation and stock options as part of her director compensation, including an option to purchase 15,335 ordinary shares at the price of $3.38 each. Her stock options will vest over three years, with immediate vesting in the event of a company takeover. She will also receive annual cash payments for her board and committee roles, as well as reimbursement for expenses related to board meetings, and has entered into standard indemnification agreements with the company and its subsidiary.
Find detailed analytics on MURA stock on TipRanks’ Stock Analysis page.
